Skip to main content
SpringerLink
Log in

Pharmacogenomic adaptation of antiretroviral therapy: overcoming the failure of lopinavir in an African infant with CYP2D6 ultrarapid metabolism

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Niehues T, Baumann U, Buchholz B et al (2006) Empfehlungen zur antiretroviralen Therapie bei HIV-infizierten Kindern - Konsensus-Statement der Pädiatrischen Arbeitsgemeinschaft AIDS (PAAD) und der Deutschen Gesellschaft für Pädiatrische Infektiologie (DGPI). Mon.schr Kinderheilkd 154:565–577

    Article  Google Scholar 

  2. Kumar GN, Dykstra J, Roberts EM et al (1999) Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. Drug Metab Dispos 27:902–908

    CAS  PubMed  Google Scholar 

  3. Kumar GN, Rodrigues AD, Buko AM, Denissen JF (1996) Cytochrome P450-mediated metabolism of the HIV-1 protease inhibitor ritonavir (ABT-538) in human liver microsomes. J Pharmacol Exp Ther 277:423–431

    CAS  PubMed  Google Scholar 

  4. Ingelman-Sundberg M (2005) Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 5:6–13

    Article  CAS  PubMed  Google Scholar 

  5. Kirchheiner J, Brøsen K, Dahl ML et al (2001) CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages. Acta Psychiatr Scand 104:173–192

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacy and Pharmacotherapy, Heinrich-Heine-University Düsseldorf, Universitätsstrasse 1, 40225, Düsseldorf, Germany

    Matthias Gorny, Stephanie Röhm & Stephanie Läer

  2. Department of Paediatric Oncology, Haematology and Immunology, Düsseldorf University Hospital, Düsseldorf, Germany

    Nezihe Morali & Tim Niehues

  3. Centre for Child and Adolescent Health, Helios Klinikum Krefeld, Krefeld, Germany

    Tim Niehues

Authors
  1. Matthias Gorny
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephanie Röhm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephanie Läer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nezihe Morali
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tim Niehues
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephanie Läer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gorny, M., Röhm, S., Läer, S. et al. Pharmacogenomic adaptation of antiretroviral therapy: overcoming the failure of lopinavir in an African infant with CYP2D6 ultrarapid metabolism. Eur J Clin Pharmacol 66, 107–108 (2010). https://doi.org/10.1007/s00228-009-0753-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-009-0753-1

Keywords

Search

Navigation